Patent Yard Sign in
Expired Canadian patentCanada

Use of human protein c for prevention and treatment of depositions of thrombocytes

CA 2126135 C · Owner: Schwarz, Hans-Peter · Inventors: Eibl, Johann; Lozano-Molero, Miguel; Schwarz, Hans-Peter

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The use of human Protein C for the prevention and treatment of deposition or aggregation of thrombocytes microparticles of, thrombocytes, and leucocytes is described. In addition an, improved method for the extra-corpereal treatment of body fluids is disclosed.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 17, 1994 and granted February 19, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 17, 2014.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 17, 2016.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 17, 1994
GrantedFebruary 19, 2002
Term endedJune 17, 2014
Patent numberCA 2126135 C
Classification (IPC)A61K38/48 +2 more

Timeline

Timeline From CIPO dates

1995199719992001200320052007200920112013Application filedJune 17, 1994Patent grantedFeb 19, 2002Term endedJune 17, 2014

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.